CO6771432A2 - Derivados de fenil-isoxazol y procedimiento para la preparación de los mismos - Google Patents
Derivados de fenil-isoxazol y procedimiento para la preparación de los mismosInfo
- Publication number
- CO6771432A2 CO6771432A2 CO13196001A CO13196001A CO6771432A2 CO 6771432 A2 CO6771432 A2 CO 6771432A2 CO 13196001 A CO13196001 A CO 13196001A CO 13196001 A CO13196001 A CO 13196001A CO 6771432 A2 CO6771432 A2 CO 6771432A2
- Authority
- CO
- Colombia
- Prior art keywords
- preparing
- isoxazole derivatives
- phenyl isoxazole
- phenyl
- derivatives
- Prior art date
Links
- ZBRDJMFLJXFIGJ-UHFFFAOYSA-N 3-phenyl-1,2-oxazole Chemical class O1C=CC(C=2C=CC=CC=2)=N1 ZBRDJMFLJXFIGJ-UHFFFAOYSA-N 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020110036172A KR101369584B1 (ko) | 2011-04-19 | 2011-04-19 | 페닐-이속사졸 유도체 및 그의 제조방법 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6771432A2 true CO6771432A2 (es) | 2013-10-15 |
Family
ID=46514985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO13196001A CO6771432A2 (es) | 2011-04-19 | 2013-08-16 | Derivados de fenil-isoxazol y procedimiento para la preparación de los mismos |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US9132126B2 (es) |
| EP (1) | EP2699566B1 (es) |
| JP (1) | JP5833143B2 (es) |
| KR (1) | KR101369584B1 (es) |
| CN (1) | CN103313982B (es) |
| AR (1) | AR086029A1 (es) |
| AU (1) | AU2012246914B2 (es) |
| CA (1) | CA2824757A1 (es) |
| CL (1) | CL2013001910A1 (es) |
| CO (1) | CO6771432A2 (es) |
| EA (1) | EA022336B1 (es) |
| HK (1) | HK1188998A1 (es) |
| IL (1) | IL227711A0 (es) |
| MX (1) | MX340098B (es) |
| PE (1) | PE20140629A1 (es) |
| SA (1) | SA112330457B1 (es) |
| SG (1) | SG192134A1 (es) |
| TW (1) | TWI434836B (es) |
| UY (1) | UY34023A (es) |
| WO (1) | WO2012144752A1 (es) |
| ZA (1) | ZA201305277B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3052353A1 (en) | 2017-02-02 | 2018-08-09 | Janssen Vaccines & Prevention B.V. | Piperazine derivatives for influenza virus inhibition |
| WO2018141854A1 (en) | 2017-02-02 | 2018-08-09 | Janssen Vaccines & Prevention B.V. | Piperazine derivatives for influenza virus inhibition |
| SG11201907034PA (en) * | 2017-02-08 | 2019-08-27 | Biotron Ltd | Methods of treating influenza |
| TWI765323B (zh) * | 2019-08-22 | 2022-05-21 | 大陸商四川海思科製藥有限公司 | 抗流感病毒化合物及其製備方法和用途 |
| CN111704587B (zh) * | 2020-06-29 | 2023-04-07 | 遵义医科大学 | 一种三氟甲基化1,3-噁嗪类化合物的合成方法 |
| CN112300147B (zh) * | 2020-11-19 | 2021-12-24 | 中国医学科学院医药生物技术研究所 | 一种吡啶类化合物及其制备方法和应用、药物组合物 |
| JP2024506000A (ja) | 2021-02-04 | 2024-02-08 | 四川海思科制▲薬▼有限公司 | Ｈａ阻害剤化合物の塩及び結晶形 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8427618D0 (en) * | 1984-11-01 | 1984-12-05 | Shell Int Research | Anticoccidial compositions |
| SK282950B6 (sk) | 1990-04-24 | 2003-01-09 | Biota Scientific Management Pty Ltd | Deriváty alfa-D-neuramínovej kyseliny, spôsob ich prípravy, ich použitie a farmaceutické prípravky na ich báze |
| BR9607098A (pt) | 1995-02-27 | 1997-11-04 | Gilead Sciences Inc | Novos inibidores seletivos de neuraminidas virais ou bacterianas |
| UA74912C2 (en) | 2001-07-06 | 2006-02-15 | Merck & Co Inc | Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes |
| ES2180456B1 (es) * | 2001-07-20 | 2004-05-01 | Laboratorios S.A.L.V.A.T., S.A. | Isoxazoles sustituidos y su utilizacion como antibioticos. |
| AU2002337843A1 (en) | 2001-10-12 | 2003-04-22 | Onconova Therapeutics, Inc. | Processes for the preparation of substituted isoxazoles and 2-isoxazolines |
| MXPA04012959A (es) * | 2002-06-29 | 2005-05-16 | Zentaris Gmbh | Arilcarbonilpiperacinas y heteroarilcarbonilpiperacinas y su uso para tratamiento de enfermedades de tumor benigno y maligno. |
| WO2004099186A1 (en) | 2003-05-06 | 2004-11-18 | Il Yang Pharm Co., Ltd. | N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof |
| KR20050051729A (ko) | 2003-11-28 | 2005-06-02 | 일양약품주식회사 | 사이클로 옥시게나제-2 억제제인 페닐 헤테로사이클의제조방법 |
| CN1687075A (zh) * | 2005-03-24 | 2005-10-26 | 天津药物研究院 | 3－苯基异噁唑－5－甲酰胺基取代β－内酰胺类衍生物及其用途 |
| WO2007008541A2 (en) | 2005-07-08 | 2007-01-18 | Kalypsys, Inc. | Cellular cholesterol absorption modifiers |
| KR100674813B1 (ko) | 2005-08-05 | 2007-01-29 | 일양약품주식회사 | Ｎ-페닐-2-피리미딘-아민 유도체 및 그의 제조방법 |
| WO2008011453A2 (en) * | 2006-07-20 | 2008-01-24 | Amgen Inc. | SUBSTITUTED AZOLE AROMATIC HETEROCYCLES AS INHIBITORS OF LLβ-HSD-1 |
| US8334385B2 (en) | 2007-11-02 | 2012-12-18 | Glenmark Generics Limited | Process for the preparation of R-sitagliptin and its pharmaceutically acceptable salts thereof |
| US20090192326A1 (en) | 2007-11-13 | 2009-07-30 | Nurit Perlman | Preparation of sitagliptin intermediate |
| CA2709784A1 (en) | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| KR101044880B1 (ko) | 2008-06-12 | 2011-06-28 | 일양약품주식회사 | 항궤양제 화합물의 합성에 유용한 중간체의 제조방법 |
| KR20100021321A (ko) | 2008-08-14 | 2010-02-24 | 일양약품주식회사 | Ν-페닐-2-피리미딘-아민 유도체의 제조방법 |
| WO2010135520A1 (en) * | 2009-05-20 | 2010-11-25 | Chimerix, Inc. | Compounds, compositions and methods for treating viral infection |
| IN2012DN01254A (es) * | 2009-08-05 | 2015-05-15 | Versitech Ltd | |
| GB2474748B (en) | 2009-10-01 | 2011-10-12 | Amira Pharmaceuticals Inc | Polycyclic compounds as lysophosphatidic acid receptor antagonists |
| JP5902172B2 (ja) | 2010-09-08 | 2016-04-13 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | 広範囲のインフルエンザ抗ウイルス薬としての新規ピペラジン類似体 |
| MX2013003227A (es) | 2010-09-28 | 2013-05-31 | Bristol Myers Squibb Co | Nuevos analogos de piperazina con grupos heteroarilo sustituidos como antivirales de la influenza de espectro amplio. |
| KR101956586B1 (ko) | 2012-03-27 | 2019-03-11 | 일양약품주식회사 | 약제학적 조성물 및 이의 제조방법 |
-
2011
- 2011-04-19 KR KR1020110036172A patent/KR101369584B1/ko not_active IP Right Cessation
-
2012
- 2012-03-30 JP JP2013551922A patent/JP5833143B2/ja not_active Expired - Fee Related
- 2012-03-30 EP EP12774858.0A patent/EP2699566B1/en not_active Not-in-force
- 2012-03-30 TW TW101111335A patent/TWI434836B/zh not_active IP Right Cessation
- 2012-03-30 SG SG2013056734A patent/SG192134A1/en unknown
- 2012-03-30 WO PCT/KR2012/002362 patent/WO2012144752A1/en active Application Filing
- 2012-03-30 EA EA201300805A patent/EA022336B1/ru not_active IP Right Cessation
- 2012-03-30 PE PE2013002002A patent/PE20140629A1/es not_active Application Discontinuation
- 2012-03-30 CN CN201280005377.5A patent/CN103313982B/zh not_active Expired - Fee Related
- 2012-03-30 MX MX2013007661A patent/MX340098B/es active IP Right Grant
- 2012-03-30 US US13/979,743 patent/US9132126B2/en not_active Expired - Fee Related
- 2012-03-30 AU AU2012246914A patent/AU2012246914B2/en not_active Ceased
- 2012-03-30 CA CA2824757A patent/CA2824757A1/en not_active Abandoned
- 2012-04-16 SA SA112330457A patent/SA112330457B1/ar unknown
- 2012-04-16 UY UY0001034023A patent/UY34023A/es not_active Application Discontinuation
- 2012-04-17 AR ARP120101314A patent/AR086029A1/es unknown
-
2013
- 2013-06-27 CL CL2013001910A patent/CL2013001910A1/es unknown
- 2013-07-12 ZA ZA2013/05277A patent/ZA201305277B/en unknown
- 2013-07-29 IL IL227711A patent/IL227711A0/en unknown
- 2013-08-16 CO CO13196001A patent/CO6771432A2/es unknown
-
2014
- 2014-03-03 HK HK14102103.4A patent/HK1188998A1/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN103313982B (zh) | 2016-02-03 |
| CN103313982A (zh) | 2013-09-18 |
| KR101369584B1 (ko) | 2014-03-06 |
| JP5833143B2 (ja) | 2015-12-16 |
| AU2012246914B2 (en) | 2015-09-24 |
| CA2824757A1 (en) | 2012-10-26 |
| EA022336B1 (ru) | 2015-12-30 |
| EP2699566B1 (en) | 2017-02-22 |
| KR20120118665A (ko) | 2012-10-29 |
| IL227711A0 (en) | 2013-09-30 |
| CL2013001910A1 (es) | 2014-04-21 |
| WO2012144752A1 (en) | 2012-10-26 |
| ZA201305277B (en) | 2014-09-25 |
| PE20140629A1 (es) | 2014-05-22 |
| MX340098B (es) | 2016-06-27 |
| EA201300805A1 (ru) | 2013-11-29 |
| EP2699566A4 (en) | 2014-09-03 |
| HK1188998A1 (zh) | 2014-05-23 |
| SA112330457B1 (ar) | 2015-08-19 |
| NZ613314A (en) | 2015-09-25 |
| SG192134A1 (en) | 2013-08-30 |
| JP2014503601A (ja) | 2014-02-13 |
| UY34023A (es) | 2012-06-29 |
| AU2012246914A1 (en) | 2013-08-15 |
| US20140031364A1 (en) | 2014-01-30 |
| TW201309658A (zh) | 2013-03-01 |
| TWI434836B (zh) | 2014-04-21 |
| MX2013007661A (es) | 2013-08-12 |
| US9132126B2 (en) | 2015-09-15 |
| AR086029A1 (es) | 2013-11-13 |
| EP2699566A1 (en) | 2014-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20130677A (es) | FORMULACIÓN PARA ANTICUERPO ANTI-a4ß7 | |
| CO6890099A2 (es) | Nuevos derivados dihidroquinolina-2-ona | |
| BR112013020540A2 (pt) | métodos para preparação de conjugados | |
| BR112013029138A2 (pt) | procedimento para assinatura digital múltipla | |
| ES2603028T8 (es) | Procedimiento para la preparación de (Z)-alfa-fluoro-beta-amino-acrilaldehídos sustituidos | |
| BR112014009302A2 (pt) | processo para preparar derivativos de quinolina | |
| CO6920293A2 (es) | Compuestos antibaterianos y método para su uso | |
| BR112014007645A2 (pt) | composto heterocíclico, métodos para a preparação de um composto heterocíclico, e, composição farmacêutica | |
| CO6771432A2 (es) | Derivados de fenil-isoxazol y procedimiento para la preparación de los mismos | |
| BR112013022411A2 (pt) | artigo absorvente e método para preparar um artigo absorvente | |
| BR112013030423A2 (pt) | método para produção de biocoque | |
| BR112014003352A2 (pt) | métodos para fabricação de construções estruturais | |
| BR112014012143A2 (pt) | soluções de colina estabilizadas e métodos para preparação das mesmas | |
| BR112014014232A2 (pt) | composto e método para a preparação de um composto | |
| ITMI20112329A1 (it) | Nuovi derivati spiro amminici | |
| BR112013013028A2 (pt) | processo para a preparação de derivados de carbamato de fenila | |
| BR112013024413A2 (pt) | compostos e métodos para a preparação de diarilpropanos | |
| DK2859822T3 (da) | Apparat til tilberedning af fødevarer | |
| CL2013002521A1 (es) | Proceso de preparación de derivados de 2-carboxamida-cicloamino-urea; y compuestos intermediarios | |
| BR112014014052A2 (pt) | processo para a preparação de 5-hidroximetilfurfural | |
| BR112014007790A2 (pt) | derivado de fenila | |
| BR112013030061A2 (pt) | aparelho para fabricação de ladrilhos | |
| CO6890113A2 (es) | Métodos para aislar ácidos 4-cloro-2-fluoro-3-fenilborónicos sustituidos | |
| BR112014008575A2 (pt) | processo para a preparação de ditina-tetracarboximidas | |
| BR112013018681A2 (pt) | método para alterar a configuração de transporte de uma peça de um artigo absorvente |